3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Neoplasms
1
Testicular Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
Interventions
Sunitinib
2
tucatinib
1
testosterone 17 beta-cypionate
1
pembrolizumab
1
dodecyl maltoside
1
cabozantinib
1
Urinary Diversion
1
Trastuzumab
1
Testosterone Propionate
1
Standard of Care
1
Saline Solution
1
Radiosurgery
1
Psychiatric Nursing
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Methyltestosterone
1
Lidocaine
1
Immune Checkpoint Inhibitors
1
Fulvestrant
1
Doxycycline
1
Cystectomy
1
Control Groups
1
Ado-Trastuzumab Emtansine
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Urologic Neoplasms
×
Psychiatric Nursing
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled